122 related articles for article (PubMed ID: 4820552)
41. [Enzymatic studies on the blood of carriers of a Tay-Sachs disease variant (variant O)].
Harzer K; Sandhoff K; Schall H; Kollmann F
Klin Wochenschr; 1971 Nov; 49(21):1189-91. PubMed ID: 5124584
[No Abstract] [Full Text] [Related]
42. Screening programs for Tay-Sachs disease in North Carolina.
Rivin BE; Slome C
N C Med J; 1977 Nov; 38(11):649-51. PubMed ID: 270612
[No Abstract] [Full Text] [Related]
43. Tay-Sachs' disease.
CUMINGS JN
Dev Med Child Neurol; 1963 Jun; 5():294-6. PubMed ID: 14024224
[No Abstract] [Full Text] [Related]
44. The enzymology of Tay-Sachs disease and its variant forms.
Tallman JF
UCLA Forum Med Sci; 1975; (18):479-99. PubMed ID: 812231
[No Abstract] [Full Text] [Related]
45. Editorial: Heterozygote screening--a social challenge.
Kaback MM
N Engl J Med; 1973 Nov; 289(20):1090-1. PubMed ID: 4742226
[No Abstract] [Full Text] [Related]
46. Studies in the ganglioside series. VII. Total synthesis of Tay-Sachs' globoside.
Shapiro D; Acher AJ; Rabinsohn Y
Chem Phys Lipids; 1973 Jan; 10(1):28-36. PubMed ID: 4699615
[No Abstract] [Full Text] [Related]
47. Carrier detection in Sandhoff disease.
Lowden JA; Ives EJ; Keene DL; Burton AL; Skomorowski MA; Howard F
Am J Hum Genet; 1978 Jan; 30(1):38-45. PubMed ID: 414620
[TBL] [Abstract][Full Text] [Related]
48. Elevated frequency of Tay-Sachs disease among Ashkenazic Jews unlikely by genetic drift alone.
Chakravarti A; Chakraborty R
Am J Hum Genet; 1978 May; 30(3):256-61. PubMed ID: 677122
[TBL] [Abstract][Full Text] [Related]
49. [Tay-Sachs disease: prenatal detection and diagnosis].
Delvin EE; Scriver CR; Pottier A; Clow CL; Goldman H
Union Med Can; 1972 Apr; 101(4):683-8. PubMed ID: 5062350
[No Abstract] [Full Text] [Related]
50. Ganglioside catabolism in hexosaminidase A-deficient adults.
Tallman JF; Brady RO; Navon R; Padeh B
Nature; 1974 Nov; 252(5480):254-5. PubMed ID: 4421837
[No Abstract] [Full Text] [Related]
51. An autopsy case of Tay-Sachs' disease.
Yutani C; Miyaji T
Acta Pathol Jpn; 1974 May; 24(3):393-404. PubMed ID: 4408157
[No Abstract] [Full Text] [Related]
52. Glycoproteins in Tay-sachs disease: isolation and carbohydrate composition of glycopeptides.
Brunngraber EG; Witting LA; Haberland C; Brown B
Brain Res; 1972 Mar; 38(1):151-62. PubMed ID: 4259417
[No Abstract] [Full Text] [Related]
53. Further studies on the elucidation of the enzymatic defect in Tay-Sachs disease.
Kolodny EH; Brady RO
Neurology; 1970 Apr; 20(4):388. PubMed ID: 5535010
[No Abstract] [Full Text] [Related]
54. Seven years experience with Tay-Sachs screening in Florida.
Tocci PM
J Fla Med Assoc; 1981 Jan; 68(1):24-9. PubMed ID: 7217914
[No Abstract] [Full Text] [Related]
55. Cultured skin fibroblasts in lipidoses. Enzymatic, histochemical, and ultrastructural relationship in Fabry's Tay-Sachs, and Sandhoff's diseases.
Yuasa T; Fukuma M; Takashima S; Takaki R
Arch Pathol Lab Med; 1980 Jun; 104(6):321-7. PubMed ID: 6246846
[TBL] [Abstract][Full Text] [Related]
56. Tay-Sachs carrier detection.
Wappner RS
J Indiana State Med Assoc; 1982 Apr; 75(4):251-4. PubMed ID: 6211494
[No Abstract] [Full Text] [Related]
57. Founder effect in Tay-Sachs disease unlikely.
Myrianthopoulos NC; Naylor AF; Aronson SM
Am J Hum Genet; 1972 May; 24(3):341-2. PubMed ID: 5028972
[No Abstract] [Full Text] [Related]
58. Controversy in human genetics: founder effect in Tay-Sachs disease.
Chase GA; McKusick VA
Am J Hum Genet; 1972 May; 24(3):339-40. PubMed ID: 5028971
[No Abstract] [Full Text] [Related]
59. Diagnosis of homozygotes and heterozygotes of GM2 gangliosidosis by hexoaminidases assay.
Harteman P; Paternotte P; Vagner F; Nabet P; Paysant P
Biomedicine; 1974 May; 20(3):242-8. PubMed ID: 4433658
[No Abstract] [Full Text] [Related]
60. Studies on Tay-Sachs disease. III. Biochemistry. A. Analytic and metabolic aspects.
KOREY SR; GONATAS J; STEIN A
J Neuropathol Exp Neurol; 1963 Jan; 22():56-66. PubMed ID: 14034770
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
